4
Changes in Ownership
RxSight, Inc. Filed Acc 0001193125-26-386841
Options or other derivatives
- Chief Financial Officer acquired 258,770 shares (grant or award)
- Chief Financial Officer returned 258,770 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Wilterding Mark · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-05 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −258,770 | 0 | D |
| 2026-09-05 | Grant or award : show line 2 in the form Stock Option (right to buy) | +258,770 | 258,770 | D |
Loading xslF345X06/ownership.xml…